Evidence map›Paper›PMID 39839305›Full record

ArticleFrontiers in aging neuroscience2024

Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infection.

Gabriela Gonzalez Aleman, George D Vavougios, Carmela Tartaglia, Nalakath A Uvais, Alla Guekht, Akram A Hosseini, Vincenzina Lo Re, Catterina Ferreccio, Giovanni D'Avossa, Hernan P Zamponi and 23 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Gabriela Gonzalez Aleman *Department of Psychology, School of Psychology and Psychopedagogy, Universidad Catolica Argentina, Buenos Aires, Argentina.
George D Vavougios *Department of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus.
Carmela Tartaglia *Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Nalakath A UvaisDepartment of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, India.
Alla GuekhtDepartment of Neurology, Moscow Research and Clinical Centre for Neuropsychiatry, Moscow, Russia.
Akram A HosseiniNottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Vincenzina Lo ReNeurology Service, Department of Diagnostic and Therapeutic Services, IRCCS ISMETT, Palermo, Italy.
Catterina FerreccioDepartment of Public Health School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Giovanni D'AvossaSchool of Psychology and Sports Sciences, Bangor University, Bangor, United Kingdom.
Hernan P ZamponiSecretariat for Mental Health and Addictions, Ministry of Health, Government of Jujuy, San Salvador de Jujuy, Argentina.
Mariana Figueredo AguiarInstituto San Lazaro de Neurociencias, Fundacion de Lucha contra los Trastornos Neurologicos y Psiquiatricos en Minorias, FULTRA, San Salvador de Jujuy, Argentina.
Agustin YecoraSecretariat for Mental Health and Addictions, Ministry of Health, Government of Jujuy, San Salvador de Jujuy, Argentina.
Mohammad Zia Ul Haq KatshuInstitute of Mental Health, University of Nottingham, Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, United Kingdom.
Vasileios T StavrouDepartment of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus.
Stylianos BoutlasDepartment of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus.
Konstantinos I GourgoulianisDepartment of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus.
Camila BoteroDepartment of Psychology, School of Psychology and Psychopedagogy, Universidad Catolica Argentina, Buenos Aires, Argentina.
Francisco González InsúaDepartment of Psychology, School of Psychology and Psychopedagogy, Universidad Catolica Argentina, Buenos Aires, Argentina.
Santiago Perez-LloretHealth Observatory, Vice Rectorate for Research, Universidad Catolica Argentina, Buenos Aires, Argentina.
Mikhail ZinchukDepartment of Neurology, Moscow Research and Clinical Centre for Neuropsychiatry, Moscow, Russia.
Anna GersamijaDepartment of Neurology, Moscow Research and Clinical Centre for Neuropsychiatry, Moscow, Russia.
Sofya PopovaDepartment of Neurology, Moscow Research and Clinical Centre for Neuropsychiatry, Moscow, Russia.
Yulia BryzgalovaDepartment of Neurology, Moscow Research and Clinical Centre for Neuropsychiatry, Moscow, Russia.
Ekaterina SviatskayaDepartment of Neurology, Moscow Research and Clinical Centre for Neuropsychiatry, Moscow, Russia.
Giovanna RusselliNeurology Service, Department of Diagnostic and Therapeutic Services, IRCCS ISMETT, Palermo, Italy.
Federica AvorioNeurology Service, Department of Diagnostic and Therapeutic Services, IRCCS ISMETT, Palermo, Italy.
Sophia WangDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States.
Paul EdisonDepartment of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
Yoshiki NiimiFaculty of Medicine, University of Tokyo, Tokyo, Japan.
Hamid R SohrabiMurdoch University Centre for Healthy Ageing, School of Psychology, Murdoch University, Murdoch, WA, Australia.
Elizabeta B Mukaetova LadinskaDepartment of Psychology and Visual Sciences, University of Leicester, Leicester, United Kingdom.
Daria NeidreLaboratory for Brain Development, Modulation and Repair, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, TX, United States.
Gabriel A de ErausquinLaboratory for Brain Development, Modulation and Repair, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, TX, United States.

Funding

Neuroimaging CoreU19AG076581 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GABRIEL Alejandro DE ERAUSQUIN, Gabriela Gonzalez_Aleman · 2023 to 2026
$32.9M
Research Education ComponentP30AG072976 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDREW J SAYKIN · 2021 to 2026
$24.1M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
MRI, Cognitive, Genetic & Biomarker Precursors of AD & Dementia in Young AdultsR01AG033040 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 2009 to 2019
$11.2M
Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for ProgressP30AG059305 · NIA · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI Gladys E. Maestre · 2018 to 2026
$5.8M
SARS-CoV-2 and Precursors of Alzheimer's Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational CohortR56AG074467 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GIRARD, TIMOTHY D, HOSSEINI, AKRAM A. · 2021 to 2021
$3.5M
The Role of COVID-19 Endothelial Cell Dysfunction and Hypercoagulability in the Development of Post-ICU Cognitive Impairment and DementiaR21AG074179 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI WANG, SOPHIA · 2021 to 2022
$436k
NIA NIH HHS P30 AG059305NIA NIH HHS P30 AG066546NIA NIH HHS P30 AG072976NIA NIH HHS R01 AG033040NIA NIH HHS R21 AG074179NIA NIH HHS R56 AG074467NIA NIH HHS U19 AG076581
6 · The paper itself

Abstract

Cognitive changes associated with PASC may not be uniform across populations. We conducted individual-level pooled analyses and meta-analyses of cognitive assessments from eight prospective cohorts, comprising 2,105 patients and 1,432 controls from Argentina, Canada, Chile, Greece, India, Italy, Russia, and the UK. The meta-analysis found no differences by country of origin. The profile and severity of cognitive impairment varied by age, with mild attentional impairment observed in young and middle-aged adults, but memory, language, and executive function impairment in older adults. The risk of moderate to severe impairment doubled in older adults. Moderately severe or severe impairment was significantly associated with infection diagnoses (chi-square = 26.57,

Indexed as

age-dependentcognitive declineCOVID-19international cohortlong COVID

Identifiers

PMID39839305
PMCPMC11747492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.